X
1. 189400-21-3
2. 144690-33-5
3. Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1h-imidazole-5-carboxylate
4. Ethyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
5. Olmesartan Ethyl Ester Trityl Impurity
6. Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-(trityltetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate
7. 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-((triphenylmethyl)-1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl)methyl)-1h-imidazole-5-carboxylic Acid Ethyl Ester
8. Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate
9. Ac-3501
10. Schembl1966071
11. Dtxsid00597607
12. Amy22221
13. Bcp12280
14. Mfcd11973634
15. Zinc72132770
16. Akos015896701
17. Ds-19558
18. Olmesartan Ethyl Ester N-1 Trityl Analog
19. Cs-0163094
20. D83710
21. 400h213
22. J-520918
23. 1-[[2'-(1-trityl-1h-tetrazole-5-yl)-1,1'-biphenyl-4-yl]methyl]-2-propyl-4-(1-hydroxy-1-methylethyl)-1h-imidazole-5-carboxylic Acid Ethyl Ester
24. 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-carboxylic Acid Ethyl Este
25. 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-carboxylicacidethylester
26. 4-(2-hydroxypropan-2-yl)-2-propyl-1-[2'-(1-triphenylmethyl-1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-1h-imidazole-5-carboxylic Acid Ethyl Ester
27. Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl }methylimidazole-5-carboxylate
28. Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl)-1h-imidazole-5-carboxylate
29. Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({2'-[1-(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl}methyl)-1h-imidazole-5-carboxylate
30. Ethyl-4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate
31. Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1h-imidazole-5-carboxylate
32. N1-trityl Olmesartan Ethyl Ester Analog; 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2?-[1-(triphenylmethyl)-1h-tetrazol-5-yl][1,1?-biphenyl]-4-yl]methyl]-1h-imidazole-5-carboxylic Acid Ethyl Ester
| Molecular Weight | 716.9 g/mol |
|---|---|
| Molecular Formula | C45H44N6O3 |
| XLogP3 | 8.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 14 |
| Exact Mass | 716.34748929 g/mol |
| Monoisotopic Mass | 716.34748929 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 54 |
| Formal Charge | 0 |
| Complexity | 1110 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
List of Suppliers
ICRI Spring Convention
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
ICRI Spring Convention
Not Confirmed
Contact SupplierICRI Spring Convention
Not Confirmed
Contact SupplierICRI Spring Convention
Not Confirmed
Contact Supplier
Market Place
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
